Our study showed that the expression levels of ER stress markers, including GRP78, PERK, IRE1α, ATF6, ATF4, XBP1S and CHOP, significantly increased with increasing concentration and duration of sorafenib treatment, suggesting that sorafenib can induce ER stress in liver cancer cells. Here, ATF4 is linked to liver cancer.